Hydrochloric Acid → 4-Piperidin-1-yl-but-2-enoic acid-HCl
反応式
C[O:2][C:3](=[O:13])[CH:4]=[CH:5][CH2:6][N:7]1[CH2:12][CH2:11][CH2:10][CH2:9][CH2:8]1.[ClH:14]>>[ClH:14].[N:7]1([CH2:6][CH:5]=[CH:4][C:3]([OH:13])=[O:2])[CH2:12][CH2:11][CH2:10][CH2:9][CH2:8]1参加物
3
実験手順
4-Piperidin-1-yl-but-2-enoic acid methyl ester (2.05 g, 11.2 mmol) and concentrated hydrochloric acid (10 mL) were combined in dioxanes (30 mL) and heated to reflux overnight. The mixture was concentrated in vacuo. The residue was crystallized from IPA to yield the desired product (390 mg, 17%). 400 MHz 1H NMR (DMSO-d6) δ 6.80 (dt, 1H, J=15.6, 7.1 Hz), 6.14 (d, 1H, J=15.6 Hz), 3.85 (d, 1H, J=7.1 Hz), 2.89 (m, 4H), 1.54 (m, 6H), MS m/z 170 (M+1).
後処理
- temperatureheated
- temperatureto reflux overnight
- concentrationThe mixture was concentrated in vacuo
- customThe residue was crystallized from IPA
出典と根拠
- ORDレコード
- ord-1925649bad4e4201952544b59341bbf5
- 出典データセット
- uspto-grants-2010_08
- 特許番号
- US07772243B2
反応ノート
読み込み中…